Biologic Injections

New approaches to management of the asthmatic lung, allergic skin, and an ever-expanding array of other allergic conditions include therapies targeting key cells and mediators driving the inflammatory responses. These therapies, called biologics, are subcutaneous injections that are administered between every two and eight weeks in office. We currently administer biologics aimed to treat asthma, chronic idiopathic urticaria and atopic dermatitis.

Some examples include:

  • Xolair (omalizumab)
  • Fasenra (benralizumab)
  • Nucala (mepolizumab)
  • Dupixent (dupilumab)

Pin It on Pinterest

Share This